Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-29FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for Rabeprazole sodium by Advagen Pharma Limited.
-
FDA approval · 2019-11-15FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for Rabeprazole sodium from Amneal Pharmaceuticals LLC (ANDA 204179).
-
FDA approval · 2019-11-14FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pantoprazole sodium from Torrent Pharmaceuticals Limited.
-
FDA approval · 2019-11-14FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
FDA approved a Supplemental Application for Pantoprazole from NorthStar RxLLC, indicating an approved revision or addition to this generic p…
-
FDA approval · 2019-10-30FDA Approved: METOCLOPRAMIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for metoclopramide hydrochloride from Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-22FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)
The FDA approved a supplemental application for ACID CONTROLLER (famotidine) submitted by H E B.
-
FDA approval · 2019-10-22FDA Approved: FAMOTIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for famotidine from Teva Pharmaceuticals USA, Inc., indicating changes or additions to the approved …
-
FDA approval · 2019-10-22FDA Approved: FAMOTIDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for famotidine by Aurobindo Pharma Limited under an ANDA, extending approval to include this manufac…
-
FDA approval · 2019-09-26FDA Approved: OMEPRAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic omeprazole in an Original Abbreviated New Drug Application, authorizing its use for the same in…
-
FDA approval · 2019-09-24FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for OMEPRAZOLE AND SODIUM BICARBONATE (omeprazole and sodium bicarbonate) from Oceanside Pharmaceuti…
-
FDA approval · 2019-09-16FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC.
-
FDA approval · 2019-09-11FDA Approved: ZANTAC 360 — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for ZANTAC 360 (famotidine) from Chattem, Inc., updating the product under an approved supplemen…
-
FDA approval · 2019-08-19FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Pantoprazole Sodium as an original generic application from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2019-08-07FDA Approved: RANITIDINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for ranitidine submitted by Rising Pharma Holdings, Inc., indicating an approved change to the p…
-
FDA approval · 2019-07-16FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for metoclopramide, a generic, indicating an updated or additional labeling under an approved A…
-
FDA approval · 2019-07-01FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for lansoprazole from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA process.
-
FDA approval · 2019-06-11FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
The FDA approved a supplemental application for PEPCID COMPLETE, a chewable tablet combining famotidine with calcium carbonate and magnesium…
-
FDA approval · 2019-05-24FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for metoclopramide hydrochloride, authorizing an updated approval for this …
-
FDA approval · 2019-05-22FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for esomeprazole magnesium from Zydus Pharmaceuticals USA Inc., a generic proton pump inhibitor for acid-rela…
-
FDA approval · 2019-05-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original generic application for esomeprazole magnesium, authorizing its use as a proton pump inhibitor. The pro…
-
FDA approval · 2019-05-10FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
The FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd., approving the generic product update.
-
FDA approval · 2019-05-03FDA Approved: OMEPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for omeprazole from Aurobindo Pharma Limited under ANDA203270.
-
FDA approval · 2019-04-25FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to add intravenous pantoprazole sodium (PROTONIX I.V.) as a new dosage form for the drug, expand…
-
FDA approval · 2019-04-25FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals (a Pfizer subsidiary).
-
FDA approval · 2019-04-09FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) by Kenvue Brands LLC.